Value of circulating GPC3 m RNA in detecting patient with hepatocellular carcinoma / Huda Ali Moustafa Karmani ; Supervised Nehad Ahmad Mosaad , Ashraf Omar Abdelaziz , Yassmin Taha Elshewey
Material type: TextLanguage: English Publication details: Cairo : Huda Ali Moustafa Karmani , 2016Description: 133 P. ; 25cmOther title:- دور الحامض الريبوزومى الرسولى للجليبكان 3 فى الكشف عن المرضى المصابين بسرطان الكب [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.07.M.Sc.2016.Hu.V (Browse shelf(Opens below)) | Not for loan | 01010110070242000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.07.M.Sc.2016.Hu.V (Browse shelf(Opens below)) | 70242.CD | Not for loan | 01020110070242000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | ||
Cai01.11.07.M.Sc.2016.Ha.R Role of blood catecholamine in essential hypertension in cases with dysmetabolic iron overload syndrome / | Cai01.11.07.M.Sc.2016.He.A Association of TAP2 gene polymorphisms (TAP2-565, TAP2- 665) with B-CLL / | Cai01.11.07.M.Sc.2016.He.A Association of TAP2 gene polymorphisms (TAP2-565, TAP2- 665) with B-CLL / | Cai01.11.07.M.Sc.2016.Hu.V Value of circulating GPC3 m RNA in detecting patient with hepatocellular carcinoma / | Cai01.11.07.M.Sc.2016.Hu.V Value of circulating GPC3 m RNA in detecting patient with hepatocellular carcinoma / | Cai01.11.07.M.Sc.2016.Kh.C Cytogenetic and molecular characterization of patients with 22q11.2 deletion syndrome / | Cai01.11.07.M.Sc.2016.Kh.C Cytogenetic and molecular characterization of patients with 22q11.2 deletion syndrome / |
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology
Aim: Is to test the clinical performance of GLYPICAN 3 gene expression as a new and specific diagnostic molecular marker in hepatocellular carcinoma by real time PCR and its protein level in serum by ELISA. The serum GPC3 protein and GPC 3 m-RNA level were measured in 30 patients with HCC and 25 patients with cirrhotic liver disease (CLD) and 25 normal healthy control by RT-PCR and by ELISA. The median values of GPC3 m-RNA by RT-PCR in patients with HCC and with CLD and in control group were 2.68ng/mL, 0.843ng/mL and 0.2ng/ml respectively. We found There was no statistically significant elevation between the HCC group as compared to the CLD groups with (p = 0.407), while both groups were significantly higher than control group (p = 0.001). The median values of serum GPC3 protein by ELISA in patients with HCC and with CLD and in control group were 2.9ng/mL, 2.4ng/ml and 2.1ng/mL, respectively. We found that there was no statistically significant difference between the HCC and the CLD groups with (p = 0.488), while both groups were significantly higher than control group (p = 0.004). The median values of serum AFP by ELISA in patients with HCC and with CLD and in control groups were 171.0 ng/mL,13ng/ml and 2.3ng/mL, respectively. We found that. There was statistically significant difference between the HCC and the CLD groups with (p=0.000). And both of them were statistcally higher than the control group p = 0.000
Issued also as CD
There are no comments on this title.